Demographic and clinical characteristics and trial treatment details by treatment group
| Variable | ELE (n=15) | Prolotherapy (n=14) | Combined treatment (n=14) |
|---|---|---|---|
| Median (IQR) | 0 | ||
| Age | 46 (40–58) | 48 (41–54) | 46 (40–57) |
| Duration of pain, mo | 21 (14.3–51) | 24 (7–78) | 6 (4.5–22) |
| n (%) | |||
| Participates in physical activity | 14 (93.3) | 14 (100) | 12 (85.7) |
| Side of pain, n (%) | |||
| Left | 6 (40.0) | 7 (50.0) | 4 (28.6) |
| Right | 4 (26.7) | 2 (14.3) | 5 (35.7) |
| Bilateral (left worse) | 1 (6.7) | 2 (14.3) | 2 (14.3) |
| Bilateral (right worse) | 4 (26.7) | 3 (21.4) | 3 (21.4) |
| Received previous treatment | 14 (93.3) | 14 (100) | 12 (85.7) |